Belpointe Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,627
| Closed | -$644K | – | 946 |
|
|
2024
Q1 | $644K | Buy |
+1,627
| New | +$644K | 0.05% | 378 |
|
|
2023
Q2 | – | Sell |
-1,862
| Closed | -$645K | – | 3393 |
|
|
2023
Q1 | $645K | Buy |
1,862
+1,584
| +570% | +$549K | 0.03% | 460 |
|
|
2022
Q4 | $65.5K | Buy |
+278
| New | +$65.5K | ﹤0.01% | 1465 |
|
|
2022
Q3 | – | Sell |
-1,504
| Closed | -$454K | – | 1241 |
|
|
2022
Q2 | $454K | Buy |
1,504
+355
| +31% | +$107K | 0.03% | 528 |
|
|
2022
Q1 | $472K | Buy |
1,149
+894
| +351% | +$367K | 0.03% | 556 |
|
|
2021
Q4 | $119K | Buy |
255
+13
| +5% | +$6.07K | 0.01% | 1121 |
|
|
2021
Q3 | $103K | Buy |
+242
| New | +$103K | 0.01% | 1153 |
|
|
2021
Q2 | – | Sell |
-2,464
| Closed | -$694K | – | 1187 |
|
|
2021
Q1 | $694K | Buy |
+2,464
| New | +$694K | 0.06% | 329 |
|
|
2020
Q3 | – | Sell |
-2,295
| Closed | -$522K | – | 827 |
|
|
2020
Q2 | $522K | Buy |
+2,295
| New | +$522K | 0.07% | 295 |
|